Cronos Group Inc (NASDAQ:CRON)
| 2.09 Delayed Data As of Dec 01 |  +0.08 / +3.96%Today’s Change | 1.64 Today|||52-Week Range 3.62 | -17.72% Year-to-Date |
Latest CRON News | Press Releases
No recent news for Cronos Group Inc.
Today’s Trading
| Previous close | 2.02 |
| Today’s open | 2.03 |
| Day’s range | 2.01 - 2.10 |
| Volume | 1,748,919 |
| Average volume (3 months) | 2,276,979 |
| Market cap | $800.3M |
Data as of 3:59pm ET, 12/01/2023
Growth & Valuation
| Earnings growth (last year) | +58.14% |
| Earnings growth (this year) | +67.22% |
| Earnings growth (next 5 years) | +11.54% |
| Revenue growth (last year) | +23.47% |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | 0.70 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| --Abivax SA | 0.00 | 0.00% |
| USNAUSANA Health Science... | -0.02 | -0.04% |
| ---- | ||
| ---- |
Data as of 3:59pm ET, 12/01/2023
Financials
| Next reporting date | February 27, 2024 |
| EPS forecast (this quarter) | -$0.02 |
| Annual revenue (last year) | $91.9M |
| Annual profit (last year) | -$168.7M |
| Net profit margin | -183.60% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Other |
No executives to display |
Corporate headquarters Toronto, Ontario |
Forecasts
